Delivery Order SPE2DB20D1100-SPE2DB25FD9V6
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $7,166.59 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on September 11, 2025, with completion targeted for September 12, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a $9,466.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Mestinon 180 mg Timespan, a medication commonly used to treat myasthenia gravis and other neuromuscular conditions. The contract, awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units, valued at $4,993.44. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was awarded on a competitive basis without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,496.72 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,963.15 firm-fixed-price contract is for the supply of Mestinon 180 mg Timespan medication. This delivery order falls under a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which provides a wide range of pharmaceutical and medical supplies to military treatment facilities and...
- This federal contract award is a $6,196.15 firm fixed-price delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,235.88, is for the supply of 180 mg Mestinon Timespan medication. The contract is a firm fixed-price delivery order with a completion date of March 27, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.77, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. This contract award is not associated with a set-aside designation....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $8,831.25 contract is for the supply of 180 mg MESTINON TIMESPAN medication, with a completion date of September 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription drugs and medical supplies to military treatment facilities, veterans' hospitals,...
- This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS2ZD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,661.88 firm fixed-price delivery order is for the supply of Mestinon 180 mg Timespan medication, with a period of performance through December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9V6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,164.41 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The firm fixed-price structure and competitive award demonstrate the vendor's capability to meet federal procurement requirements for specialized pharmaceutical products and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/11/25 |